Philippe E Laurent

Summary

Affiliation: BD Biosciences
Country: USA

Publications

  1. ncbi Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines
    Aurélie Laurent
    Palliative Care Unit, Centre Hospitalier Lyon Sud, 69310 Pierre Benite, France
    Vaccine 25:6423-30. 2007
  2. pmc Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers
    Cecile Berteau
    BD Medical Pharmaceutical Systems, Le Pont de Claix
    Patient Prefer Adherence 4:379-88. 2010
  3. pmc A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis
    Amer Jaber
    Merck Serono International S A, Geneva, Switzerland
    BMC Neurol 8:38. 2008
  4. doi Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults
    Philippe E Laurent
    BD Medical Pharmaceutical Systems, rue Aristide Bergès, Le Pont de Claix, France
    Vaccine 28:5850-6. 2010
  5. ncbi Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system
    Philippe E Laurent
    BD Medical Pharmaceutical Systems, 11, rue Aristide Bergès, 38800 Le Pont de Claix, France
    Vaccine 25:8833-42. 2007
  6. doi Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook
    John A Mikszta
    BD Technologies, 21 Davis Drive, Research Triangle Park, NC 27709, USA
    Expert Rev Vaccines 7:1329-39. 2008

Collaborators

  • John A Mikszta
  • Jean Francois Nicolas
  • Cecile Berteau
  • Julie Berube
  • Amer Jaber
  • Aurélie Laurent
  • Mathilde Latreille
  • Herve Abry
  • Yves Donazzolo
  • Joël Cotten
  • Florence Schwarzenbach
  • Celine Feger
  • Lionel Vedrine
  • Gian B Bozzato
  • Wes A Prais
  • Frederic Mistretta
  • Anca Hennino
  • Karima Dahel
  • Catherine Goujon
  • David Bottigioli

Detail Information

Publications6

  1. ncbi Echographic measurement of skin thickness in adults by high frequency ultrasound to assess the appropriate microneedle length for intradermal delivery of vaccines
    Aurélie Laurent
    Palliative Care Unit, Centre Hospitalier Lyon Sud, 69310 Pierre Benite, France
    Vaccine 25:6423-30. 2007
    ..The deltoid, suprascapular and waist are the most appropriate body sites...
  2. pmc Evaluation of performance, safety, subject acceptance, and compliance of a disposable autoinjector for subcutaneous injections in healthy volunteers
    Cecile Berteau
    BD Medical Pharmaceutical Systems, Le Pont de Claix
    Patient Prefer Adherence 4:379-88. 2010
    ..To verify its performance and evaluate its acceptance, a clinical study was conducted in healthy volunteers, comparing SC injections performed by subjects using the autoinjector with SC injections performed by nurses using a syringe...
  3. pmc A novel needle for subcutaneous injection of interferon beta-1a: effect on pain in volunteers and satisfaction in patients with multiple sclerosis
    Amer Jaber
    Merck Serono International S A, Geneva, Switzerland
    BMC Neurol 8:38. 2008
    ....
  4. doi Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults
    Philippe E Laurent
    BD Medical Pharmaceutical Systems, rue Aristide Bergès, Le Pont de Claix, France
    Vaccine 28:5850-6. 2010
    ..In contrast, the epidermal delivery route did not produce an immune response against the rabies vaccine...
  5. ncbi Evaluation of the clinical performance of a new intradermal vaccine administration technique and associated delivery system
    Philippe E Laurent
    BD Medical Pharmaceutical Systems, 11, rue Aristide Bergès, 38800 Le Pont de Claix, France
    Vaccine 25:8833-42. 2007
    ..These evaluations showed that microinjection system can make the practice of ID vaccination easy to perform, reliable and safe, thus setting the stage for broader clinical application of ID vaccine delivery...
  6. doi Cutaneous delivery of prophylactic and therapeutic vaccines: historical perspective and future outlook
    John A Mikszta
    BD Technologies, 21 Davis Drive, Research Triangle Park, NC 27709, USA
    Expert Rev Vaccines 7:1329-39. 2008
    ..The 5-year outlook, however, appears quite promising as new cutaneous delivery systems advance through clinical trials and become available for more widespread clinical and commercial use...